27.4.2022
•
News
Real estate and construction
KSB Advises on PPF Real Estate’s and Karlín Group’s Joint Entry into Prague’s Residential Development Market
PPF Real Estate – PPF Group’s real estate division – is entering the residential property market in Prague in cooperation with Karlín Group. The agreement between the two companies includes development projects that involve a total investment worth CZK 4 billion.
The first joint project is the “Simply Holešovice” residential project near the Bubny railway station, which will offer more than 200 apartments and rental units.
KSB’s team (Petr Kasík, Jakub Porod, Zuzana Slabá, Filip Řehák) advised PPF Real Estate and was in charge of, in particular, conducting due diligence and negotiating the transaction documentation.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
